logo logo logo
CONSULT THE EXPERT
SYMPOSIUM
ABSTRACTS

This page is for healthcare professionals only.
A Galapagos product was discussed at these events.

Galapagos @ EULAR 2023

 

The annual EULAR European Congress of Rheumatology is one of the most anticipated events in the rheumatology calendar. Each year, the scientific programme includes a wide range of sessions presented by some of the world’s leading specialists, who together explore basic science, traditional medicine and clinical practice, as well as present a wealth of important new data.

Galapagos is proud to have been a sponsor at EULAR 2023 and to have hosted both a satellite symposium and consult-the-expert session.
We enjoyed meeting you all at EULAR 2023 and hope you will join us again in the future!

Satellite
symposium

Did you miss the live event? Watch Professor Ennio Giulio Favalli, Professor Anja Strangfeld and Dr James Galloway in the EULAR European Congress of Rheumatology 2023 Galapagos-sponsored industry symposium on-demand!
 
During this session, our expert faculty:
 
  • Reviewed the key considerations when selecting a treatment for a patient with RA
  • Explored the efficacy and safety of JAK inhibitors in RA, including filgotinib clinical trial and real-world data
  • Discussed the practical use of JAK inhibitors in the treatment of patients with RA in the context of recent developments in the RA treatment landscape

Satellite
symposium
faculty

 

No Teaser Found

{{teaser.openTeaserLinkText}} {{teaser.openTeaserLinkText}}

Consult-the-
Expert session

If you missed the live event, you can now watch Professor Roberto Caporali and Professor Lorenzo Dagna in the EULAR European Congress of Rheumatology 2023 Galapagos-sponsored Consult-the-Expert session on-demand!
 

During this session, our experts:

  • Reviewed recent developments in the RA treatment landscape and the potential implications for clinical practice
  • Discussed the practical use of JAK inhibitors in RA, including considerations for treatment selection and patient management

Consult-the-Expert session faculty

 

No Teaser Found

{{teaser.openTeaserLinkText}} {{teaser.openTeaserLinkText}}

Abstracts*

Posters are available as soon as they are presented at EULAR (please see presentation times below).

Galapagos driven abstracts

Kevin Winthrop, Daniel Aletaha, Roberto Caporali, Yoshiya Tanaka, Tsutomu Takeuchi, Paul Van Hoek, Pieter-Jan Stiers, Vijay Rajendran, Katrien Van Beneden, Jacques-Eric Gottenberg, Gerd R. Burmester
Poster presentation
Poster number: POS0844 
Date: 01 June 2023, 14:45–15:45 CEST
Session: Poster view
GO TO POSTER
Peter C. Taylor, Yoshiya Tanaka, Emily Aiello, Thomas Debray, Chris Watson, Kristina Harris, Gerd Rüdiger Burmester
Poster presentation
Poster number: POS0843 
Date: 01 June 2023, 14:45–15:45 CEST
Session: Poster view
GO TO POSTER
Rene Westhovens, Rieke Alten, Lorenzo Dagna, Arthur Kavanaugh, Kevin L. Winthrop, Jane Barry, Robin Besuyen, Claudio Corallo, Dick de Vries, Nicolas Martin, Chris Watson, Mark C. Genovese, Alberto Spindler, Mykola Stanislavchuk, Maria Greenwald, Paul Emery
Poster presentation
Poster number: POS0829
Date: 01 June 2023, 14:45–15:45 CEST
Session: Poster view
GO TO POSTER
Maya H Buch, Jose A Gómez-Puerta, Gerd Rüdiger Burmester, Bernard G Combe, Vijay Rajendran, Pieter-Jan Stiers, Paul Van Hoek, Katrien Van Beneden, Jacques-Eric Gottenberg, Yoshiya Tanaka, Daniel Aletaha, René Westhovens, Roberto Caporali
Poster presentation
Poster number: POS0308 
Date: 03 June 2023, 10:00–11:30 CEST
Session: Poster tour
Poster discussion session: 10:05–10:10 CEST
GO TO POSTER
Maya H Buch, Daniel Aletaha, Roberto Caporali, Bernard G Combe, Hendrik Schulze-Koops, Jacques-Eric Gottenberg, Yoshiya Tanaka, Ricardo Blanco, Tsutomu Takeuchi, Edmund V Ekoka Omoruyi, Katrien Van Beneden, Vijay Rajendran, Chris Watson, Francesco De Leonardis, Paul Emery
Poster presentation
Poster number: POS0853  
Date: 01 June 2023, 14:45–15:45 CEST
Session: Poster view
GO TO POSTER
Xavier Mariette, Sven Borchmann, Sandrine Aspeslagh, Jaime Calvo-Alén, Richard Moriggl, Zoltan Szekanecz, Francesco De Leonardis, Nadia Verbruggen, Paul Van Hoek, Marc Schmalzing, Andreas Stallmach, Christina Charles-Schoeman, Vijay Rajendran, Christine Rudolph, Chris Watson, Yoshiya Tanaka, Ernest Choy 
Poster presentation
Poster number: POS0824 
Date: 01 June 2023, 14:45–15:45 CEST
Session: Poster view
GO TO POSTER
Peter C. Taylor, Arthur Kavanaugh, Peter Nash, Janet Pope, Georg Pongratz, Bruno Fautrel, Rieke Alten, Ken Hasegawa, Shangbang Rao, Dick de Vries, Pieter-Jan Stiers, Chris Watson, Rene Westhovens
Abstract publication only
Ennio Giulio Favalli, Maya H Buch, James Galloway, Arnaud Constantin, Patrick Durez, Paul Van Hoek, Christopher Watson, Pieter-Jan Stiers, Vijay Rajendran, Katrien Van Beneden, Tsutomu Takeuchi, Bernard Combe
Abstract publication only
*Filgotinib should only be used if no suitable treatment alternatives are available in patients 65 years of age and older, with history of atherosclerotic cardiovascular disease or other cardiovascular risk factors (such as current or past long-time smokers), or with malignancy risk factors (e.g. current malignancy or history of malignancy). 

Posters are available as soon as they are presented at EULAR (please see presentation times below).

Roberto Caporali, Jérôme Avouac, Karen Bevers, Gerd Burmester, Thomas P.A. Debray, Francesco De Leonardis, Kristina Harris, Neil Betteridge, Susana Romero Yuste, Patrick Verschueren, Monia Zignani, James Galloway 
Poster presentation
Poster number: POS0466 
Date: 31 May 2023, 15:30–16:30 CEST
Session: Poster view
GO TO POSTER
Olaf Schultz, Christoph Fiehn, Christian Kneitz, Nils Picker, Daniel Kromer, Monia Zignani, Francesco De Leonardis, Hans-Dieter Orzechowski, Margot Gurrath, Klaus Krüger
Poster presentation
Poster number: POS0851 
Date: 01 June 2023, 14:45–15:45 CEST
Session: Poster view
GO TO POSTER
Patrick Verschueren, Jérôme Avouac, Karen Bevers, Susana Romero Yuste, Roberto Caporali, Thomas P.A. Debray, Francesco De Leonardis, James Galloway, Monia Zignani, Gerd Burmester
Abstract publication only
Rieke Alten, Juan Carlos Nieto Gonzalez, Peggy Jacques, Carlomaurizio Montecucco, Robert Moots, Helga Radner, Sebastian Heidenreich, Chiara Whichello, Nicolas Krucien, Monia Zignani, Harald Vonkeman, Katrien Van Beneden
Poster presentation
Poster number: POS0600-HPR 
Date: 31 May 2023, 15:30–16:30 CEST
Session: Poster view
GO TO POSTER
*Filgotinib is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more DMARDs. Filgotinib may be used as monotherapy or in combination with methotrexate.
Filgotinib should only be used if no suitable treatment alternatives are available in patients 65 years of age and older, with history of atherosclerotic cardiovascular disease or other cardiovascular risk factors (such as current or past long-time smokers), or with malignancy risk factors (e.g. current malignancy or history of malignancy).

News and views

Stay up to date!

I would like to receive informational and promotional communication via e-mail concerning Galapagos' products and services. 

This field is required
This field is required
Regex pattern not matched.
You must maintain minimum length.
You must maintain maximum length.
Value did not matched with each other.
This field is required
Regex pattern not matched.
You must maintain minimum length.
You must maintain maximum length.
Value did not matched with each other.
This field is required
Regex pattern not matched.
You must maintain minimum length.
You must maintain maximum length.
Value did not matched with each other.
This field is required
Regex pattern not matched.
You must maintain minimum length.
You must maintain maximum length.
Value did not matched with each other.
This field is required
This field is required
Regex pattern not matched.
You must maintain minimum length.
You must maintain maximum length.
Value did not matched with each other.

Related Events

See all our events
VISIT EVENTS MAIN

Visit our website to register for access to our full catalogue of medical education! 
logo

GALAPAGOS and the GALAPAGOS logo are registered or pending trademarks of Galapagos NV.

© 2023 Galapagos NV. All rights reserved

GL-RA-FIL-202304-00003 | June 2023

Popular Pages
Other Categories
Follow us here too
logo

GALAPAGOS and the GALAPAGOS logo are registered or pending trademarks of Galapagos NV.

© 2023 Galapagos NV. All rights reserved

GL-RA-FIL-202304-00003 | June 2023

Privacy notice
Cookie policy
Terms of use
Site map
Disclaimer

© Copyright 2021 Galapagos NV

galapagos-health galapagos-health galapagos-health

GALAPAGOS and the GALAPAGOS logo are registered or pending trademarks of Galapagos NV.
© 2022 Galapagos NV. All rights reserved.

GL-RA-FIL-202104-00008 12/22

Popular Pages
Other Categories
Follow us here too
galapagos-health galapagos-health galapagos-health

GALAPAGOS and the GALAPAGOS logo are registered or pending trademarks of Galapagos NV.
© 2022 Galapagos NV. All rights reserved.

GL-RA-FIL-202104-00008 12/22

Privacy notice
Cookie policy
Terms of use
Site map
Disclaimer

© Copyright 2021 Galapagos NV